Drugmaker Shire buys bowel drug rights from Pfizer

Drugmaker Shire buys bowel drug rights from Pfizer


Irish drugmaker Shire Plc said on Tuesday it would buy from Pfizer Inc the rights to an experimental drug, designed to treat moderate-to-severe inflammatory bowel disease. The drug, PF-00547659, has successfully completed mid-stage studies and late-stage trials are expected to begin after consultation with global health authorities, Shire said in a statement Inflammatory bowel disease is a condition that affects either part or all of the digestive tract and the cause of the disease is unknown.



from Biotech News